Efficacy and safety of entecavir and/or tenofovir for prophylaxis and treatment of hepatitis b recurrence postliver transplant

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 3167-3168

  Jimenez Perez M ^a   Seaz Gomez A B ^a   Mongil Poce, L ^a   Lozano Rey, J M ^a   De La Cruz Lombardo, J ^a   Rodrigo Lopez J M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; TENOFOVIR;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENCE RISK; UNSPECIFIED SIDE EFFECT;

ADENINE; ADULT; AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; FEMALE; GUANINE; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; RECURRENCE;

EID: 77958604866     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.05.127     Document Type: Article

References (9)

1. D. Mutimer Review article: hepatitis B and liver transplantation Aliment Pharmacol Ther 23 2006 1031
2. N. Terrault, B. Roche, and D. Samuel Management of the hepatitis B virus in the liver transplantation setting: a European and an American perpective Liver Transpl 11 2005 716
3. F.G. Villamil Prophylaxis with anti-HBs immune globulins and nuecleoside analogues after liver transplantation for HBV infection J Hepatol 39 2003 466
4. A.S.F. Lok, and B.J. McMahon AASLD Practice Guidelines Chronic hepatitis B: Update 2009 Hepatology 50 2009 1
5. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of chronic hepatitis B J Hepatol 50 2009 227
6. J. Petersen, M. Lutgehetmann, and F. Zoulin Entecavir and tenofvir combination therapy in chronic hepatitis B: rescue therapy in patients with advanced fibrosis and multiple previous treatment failures Results from an international multicenter cohort study Hepatology 50 suppl 4 2009 496A
7. Y. Liaw, M. Raptopoulou-Gigi, and Cheinquer Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with evidence of hepatic decompensation Hepatology 50 suppl 4 2009 505A
8. Y. Liaw, C. Lee, and U.S. Akarca Interim results of a double-blind, randomized phase 2 study of the safety of tenefovir disoproxil fumurate, emtricitabine plus tenofovir disoproxil fumarate and entecavir in the treatment of chronic hepatitis B subjects with decompensated liver disease Hepatology 50 suppl 4 2009 409A
9. D. Amarapurkar Efficacy of combination of entecavir and tenofovir treatment in hepatitis B related decompensated chronic liver disease: pilot study J Hepatol 50 suppl 1 2009 327